Pasithea Therapeutics Corp.
KTTA
$0.58
$0.00-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.47% | -218.18% | -1.25% | 3.88% | 7.71% |
| Total Depreciation and Amortization | -3.02% | -2.96% | 11.89% | -0.37% | 0.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,954.67% | 3,889.57% | -50.05% | -66.53% | -90.96% |
| Change in Net Operating Assets | -312.55% | -124.44% | 71.42% | 28.43% | 133.57% |
| Cash from Operations | -56.66% | -120.91% | 7.39% | 4.21% | 29.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.95% | 18,820,200.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -64.44% | -102.56% | -- | -- |
| Cash from Financing | -99.95% | 239,174.58% | -102.56% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -98.22% | 146.86% | 293.10% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.87% | 2,193.02% | -314.80% | 146.41% | 63.41% |